These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17221215)

  • 1. Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.
    Utikal J; Schadendorf D; Ugurel S
    Arch Dermatol Res; 2007 Mar; 298(10):469-77. PubMed ID: 17221215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old and new serological biomarkers in melanoma: where we are in 2009.
    Mouawad R; Spano JP; Khayat D
    Melanoma Res; 2010 Apr; 20(2):67-76. PubMed ID: 20093989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor biomarkers in melanoma.
    Ugurel S; Utikal J; Becker JC
    Cancer Control; 2009 Jul; 16(3):219-24. PubMed ID: 19556961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum proteomic profiling reveals potential biomarkers for cutaneous malignant melanoma.
    Solassol J; Du-Thanh A; Maudelonde T; Guillot B
    Int J Biol Markers; 2011; 26(2):82-7. PubMed ID: 21607923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of circulating tumor DNA in advanced cutaneous squamous cell carcinoma: Potential opportunities and challenges.
    Sun H; Shen W; Zhong HJ
    J Am Acad Dermatol; 2024 Aug; 91(2):e31-e32. PubMed ID: 38593973
    [No Abstract]   [Full Text] [Related]  

  • 6. Serological immunomarkers in cutaneous T cell lymphoma.
    Hassel JC; Meier R; Joller-Jemelka H; Burg G; Dummer R
    Dermatology; 2004; 209(4):296-300. PubMed ID: 15539892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased HMGB1 levels in lesional skin and sera in patients with cutaneous T-cell lymphoma.
    Senda N; Miyagaki T; Kamijo H; Nakajima R; Oka T; Takahashi N; Suga H; Yoshizaki A; Asano Y; Sugaya M; Sato S
    Eur J Dermatol; 2018 Oct; 28(5):621-627. PubMed ID: 30378541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a Circulating MicroRNA Profile as a Biomarker of Metastatic Cutaneous Melanoma.
    Armand-Labit V; Meyer N; Casanova A; Bonnabau H; Platzer V; Tournier E; Sansas B; Verdun S; Thouvenot B; Hilselberger B; Doncescu A; Lamant L; Lacroix-Triki M; Favre G; Pradines A
    Acta Derm Venereol; 2016 Jan; 96(1):29-34. PubMed ID: 26039581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rare variants of cutaneous T-cell lymphomas].
    Goerdt S; Trautmann C; Kütting B; Ramaker J; Schmuth M; Thiel E; Luger T; Stein H; Orfanos CE
    Hautarzt; 1996 Feb; 47(2):96-105. PubMed ID: 8868452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of proteomics to the identification of biomarkers for cutaneous malignant melanoma.
    Bougnoux AC; Solassol J
    Clin Biochem; 2013 Apr; 46(6):518-23. PubMed ID: 23262402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics: An emerging approach for the diagnosis and classification of cutaneous squamous cell carcinoma and its precursors.
    Azimi A; Kaufman KL; Kim J; Ali M; Mann GJ; Fernandez-Penas P
    J Dermatol Sci; 2020 Jul; 99(1):9-16. PubMed ID: 32312638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating melanoma cells as a potential biomarker to detect metastasis and evaluate prognosis.
    Hida T; Yoneta A; Wakamatsu K; Yanagisawa K; Ishii-Osai Y; Kan Y; Kato J; Yamashita T
    Australas J Dermatol; 2016 May; 57(2):145-9. PubMed ID: 26931184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum markers of cutaneous melanoma.
    Perrotta R; Bevelacqua Y; Malaguarnera G; Paladina I; Giordano M; Malaguarnera M
    Front Biosci (Elite Ed); 2010 Jun; 2(3):1115-22. PubMed ID: 20515782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma.
    Delfau-Larue MH; Laroche L; Wechsler J; Lepage E; Lahet C; Asso-Bonnet M; Bagot M; Farcet JP
    Blood; 2000 Nov; 96(9):2987-92. PubMed ID: 11049975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anti-BPAG1 autoantibody level is not a useful biomarker for cutaneous melanoma.
    Gambichler T; Scheitz R; Höxtermann S
    Melanoma Res; 2016 Feb; 26(1):88-9. PubMed ID: 26301970
    [No Abstract]   [Full Text] [Related]  

  • 16. The prognostic role of detection of circulating melanoma cells in the blood.
    Dutcher JP
    J Clin Oncol; 2003 Mar; 21(5):757-9. PubMed ID: 12610168
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum selenium in melanoma and epidermotropic cutaneous T-cell lymphoma.
    Deffuant C; Celerier P; Boiteau HL; Litoux P; Dreno B
    Acta Derm Venereol; 1994 Mar; 74(2):90-2. PubMed ID: 7911634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of chromosomal aberrations and epigenetic changes in peripheral blood samples to identify patients with melanoma.
    Jakub JW; Grotz TE; Jordan P; Hunter E; Pittelkow M; Ramadass A; Akoulitchev A; Markovic S
    Melanoma Res; 2015 Oct; 25(5):406-11. PubMed ID: 26225582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous CD4+ small-to-medium-sized pleomorphic T-cell lymphoma: a rare case report of infant.
    Li D; Guo B; Li D; Chang C; Lu Q
    J Clin Pathol; 2015 Oct; 68(10):855-8. PubMed ID: 26112823
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
    Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
    Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.